Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Neurodegenerative Diseases

• Probiotics in Mild Alzheimer's Disease
• MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
• AMX0035 and Progressive Supranuclear Palsy
• Continuation Study for Latozinemab
• [18F]MC225-PET in Neurodegenerative Disease
• A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
• Role of Saffron and Chamomile in the Management of Parkinson's Disease
• Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
• AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy
• A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
• An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
• Immunohistochemical Study of Neurodegenerative Diseases
• A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
• Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients
• Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
• Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
• Study to Assess the Efficacy of XPro™ in Patients With Mild Alzheimer's Disease With Biomarkers of Inflammation
• A FIH Study to Assess the Safety and Tolerability of NS Intravenous NS101 Infusion
• Dopaminergic Therapy for Frontotemporal Dementia Patients
• Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders
• Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
• Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
• A Study of CST-103 Co-administered With CST-107 in Subjects With Neurodegenerative Disorders
• A First in Human Study to Assess the Safety,Tolerability and Pharmacokinetics of ONO-2808 in Healthy Participants
• Exploratory Evaluation of [11C]MPC6827
• Tocotrienols in Parkinson's Disease (PD)
• Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
• Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients
• Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
• Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety
• Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies
• Citicoline Concentration in Human Vitreous
• PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel TSPO Radioligand
• Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study
• Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
• A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
• A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
• To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
• Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
• PET Tau - Neurodegenerative Disease Imaging
• AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)
• Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
• [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease
• Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
• Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
• Reproducibility of the 11C-PBR28 PET Signal
• Effect of Nicotinamide in Friedreich's Ataxia
• Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
• Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
• Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development
• DaTSCAN Imaging in Aging and Neurodegenerative Disease
• Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)
• Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)
• Dyskinesia in Parkinson's Disease (Study P04501)
• Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects
• Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System